PureTech's Vedanta Biosciences Announces Initiation of Phase 1 Clinical Study with Janssen of Microbiome-Derived Product Candidate for Inflammatory Bowel Disease

Press/Media

Period27 Nov 2018

Media coverage

1

Media coverage

  • TitlePureTech's Vedanta Biosciences Announces Initiation of Phase 1 Clinical Study with Janssen of Microbiome-Derived Product Candidate for Inflammatory Bowel Disease
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date27/11/18
    PersonsJeremiah Faith
View all 1
View less